UPDATED WITH QUOTES FROM COMPANY South Korean pharmaceutical company Celltrion has won permission for phase one clinical trials of a potential Covid-19 treatment in the United Kingdom. Celltrion’s CT-P59, an anti-viral antibody treatment, had the green light for the trial in patients with mild Covid-19 from the UK medicines regulator on Thursday, the company said. […]
Thank you for registering!
An account was already registered with this email. Please check your inbox for an authentication link.